OKUR vs VRTX · P/E 72, rev $2.0M vs P/E 30, rev $3.33B
OnKure Therapeutics, Inc. (OKUR) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
OKUR currently screens at market cap $76.6M and trailing P/E 71.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the OKUR and VRTX stock pages for the full models.
Not investment advice.